Vijay Pande

General Partner, a16z Bio + Health · 38 appearances on the record.

computed by AI from the episodes · how this works → · full disclaimer →

Vijay Pande is a General Partner at a16z Bio + Health. He focuses on the intersection of technology, biology, healthcare systems, and artificial intelligence in drug discovery.

197statements → 110claims → 30claims resolved → 77%fully supported → 3.62/5average certainty → 2.27/5average debate potential → 3.9/5argument clarity · the sources → 6said about them ↓

23 supported 3 partly supported 4 contradicted 3 not yet assessed 72 not checkable as stated how the 110 claims stand · each chip opens the sources

54 predictions · 56 assertions · 16 opinions · 65 insights · 5 disclosures · 1 what if · every statement was checked. The predictions and assertions are the 110 claims: statements the public record can support or contradict. 35 are resolved, 3 are not yet assessed, and 72 name no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Vijay argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

Their most notable supported claim

Assertion Supported
A large fraction of published biological experiments are irreproducible, says Vijay Pandey
“It comes up all the time that a large fraction of biology experiments are just irreproducible.”
Vijay Pande Jan 2, 2019 ▶ 14:29 a16z Podcast | When Bio Meets Computer Science

Their most notable contradicted claim

Assertion Contradicted
Pande: FDA rejects new drugs that are cheaper but equal in efficacy
“If you had a drug that was as good as the best drug, but cheaper, That still can't get that won't go by the FDA because they actually has to be better than the last drug, even if it's not better scientifically, but it's better in other ways.”
Vijay Pande Dec 20, 2023 ▶ 13:03 Tony Robbins on the Future of Health & Longevity

Expressed certainty vs assessment result

none yet certainty 1
none yet certainty 2
67% certainty 3
84% certainty 4
100% certainty 5

weighted support: a fully supported claim counts one, a partly supported claim counts half. Each filled bar is clickable and opens exactly those claims; "none yet" means nothing said at that certainty level has resolved yet

Argument clarity: do they answer the question? how? →

3.9 / 5 directness 4 · coherence 4.1 · precision 3.3 · compression 3.4

redirected or did not address 2 of 17 assessed questions (12%). Watch them ▸

This is a score against a rubric. It is not a rank. Every host question → answer exchange is scored with names hidden on directness, coherence, precision and compression, 1–5 each, on meaning alone: disfluencies are ignored, and only raw unedited episodes count. This is the score that measures thought. Every scored exchange, scores shown → · The rubric and its checks →

How they sound: speaking style how? →

285 words/min while actually speaking · 21.9 um and uh per 1k words · 13 false starts per 1k · 32.2% of pauses land inside a clause

Um and uh per 1,000 words, year by year. Hover a point for the year's tape.

10203020162017201820192023202420252016 · 17.8 per 1k · 4 episodes2017 · 18.5 per 1k · 9 episodes2018 · 30.5 per 1k · 4 episodes2019 · 25.5 per 1k · 5 episodes2023 · 15.4 per 1k · 4 episodes2024 · 19.1 per 1k · 5 episodes2025 · 17 per 1k · 2 episodes

Measured by listening to the audio itself: 65,442 words across 34 episodes of raw-level tape, transcribed verbatim with every um and uh kept, each one attributed only where the alignment onto our timed stream is unambiguous. These are measurements of speaking style. We do not rank them: across this corpus, fluency and argument quality are nearly uncorrelated (ρ≈0.2), and smooth talking does not signal clear thinking. How it's measured →

Everything Vijay Pande said on the a16z Podcast that made the record, most notable first. Filter by type, assessment or year in the ledger →

Prediction Not checkable as stated
Pande: Cancer could easily not exist in 10 years
“Cancer could easily just not exist in 10 years, and that's due to this change in how we think about things, and there's all these things on the back end.”
Vijay Pande Jul 15, 2017 ▶ 12:46 On Machine Learning in Medicine and More
Prediction Not checkable as stated
Vijay Pande: Compute costs will fall a million-fold over 20 years
“The nice thing about the exponentials is that, you know, things will go down a factor of a thousand, like, every 10 years on the Moore's Law side, and we'll continue to see that. So, a thousand, maybe in 20 years, a million, you know, a thousand times a thousa…”
Vijay Pande Sep 5, 2024 ▶ 9:59 Implementation, Data, Impact of Healthcare AI with Julie and Vijay
Insight
Pande: Healthcare AI needs a 10x improvement threshold to overcome stigma
“Yeah, so I think the bar is different. This might be the magic has to get to 10 X. Mm-hmm. Something where 10% is probably within noise and without doubt or something like that, but 10 X is kind of the thing where, like, okay, okay. We have to think of things …”
Vijay Pande Sep 5, 2024 ▶ 19:49 Implementation, Data, Impact of Healthcare AI with Julie and Vijay
Prediction Not checkable as stated
Pande: Healthcare service providers will eventually transition into AI companies
“Well, you can imagine a services company that's providing some sort of healthcare service. It's training AI with its workers. And then the easy things, which are probably the boring things anyways, AI starts to do. And then the more interesting, complicated th…”
Vijay Pande Sep 5, 2024 ▶ 22:36 Implementation, Data, Impact of Healthcare AI with Julie and Vijay
Assertion Contradicted
Pande: FDA rejects new drugs that are cheaper but equal in efficacy
“If you had a drug that was as good as the best drug, but cheaper, That still can't get that won't go by the FDA because they actually has to be better than the last drug, even if it's not better scientifically, but it's better in other ways.”
Vijay Pande Dec 20, 2023 ▶ 13:03 Tony Robbins on the Future of Health & Longevity
Prediction Open · timeframe Jan 2028
Pande: The world's largest company will be in consumer health tech
“The biggest company in the world will be a consumer health tech company.”
Vijay Pande Jan 27, 2023 ▶ 46:42 2023 Big Ideas in Technology (Part 2)
Assertion Not checkable as stated
Pande: AI is turning scientific discovery into an industrialized process
“Today, what I want to talk about is how AI is industrializing discovery.”
Vijay Pande Nov 21, 2019 ▶ 0:21 AI is Industrializing Discovery
Assertion Partly supported
Pande: AI biomarkers achieve 90% accuracy compared to 50% for PSA tests
“Like a PSA test is roughly 50% accurate. These new AI discovered biomarkers are considerably more accurate, you know, with sensitivity and specificities in the nineties.”
Vijay Pande Nov 21, 2019 ▶ 6:37 AI is Industrializing Discovery
Prediction Not checkable as stated
Pande: Animal models will become machine learning inputs, not pass/fail tests
“We're not going to think about these models as some sacrosanct up or down vote. That they are basically going to be features into machine learning where you're going to have this as the inputs and label data in humans from previous experiments to be able to co…”
Vijay Pande Nov 21, 2019 ▶ 19:04 AI is Industrializing Discovery
Prediction Not checkable as stated
Pande: Machine learning will cut protein therapeutic costs by up to 90%
“If you could use machine learning methods to decrease the cost, and there's a lot of reason to think the cost could go down by half or a fifth or even a 10th, that would have a huge impact on drugs, as well as all the different proteins that are used in the bi…”
Vijay Pande Nov 21, 2019 ▶ 19:46 AI is Industrializing Discovery
Prediction Not checkable as stated
Pande: Real-world evidence will surpass clinical trials in utility
“And what I think we'll start to see is, especially as new statistical methods come online, that real world evidence will be very useful, in some ways will be more useful than what you can do in a clinical trial, both due to power and due to the fact of real li…”
Vijay Pande Jan 17, 2019 ▶ 19:08 a16z Podcast | Dark Data in Healthcare
Opinion
Pande: Many students attend graduate school out of low risk tolerance
“A lot of people go to grad school because they're actually Not very risk tolerant. You know, that grad school is a comfortable thing to do.”
Vijay Pande Jan 2, 2019 ▶ 14:54 a16z Podcast | Breaking Into Bio
Insight
Pande: A dual-skilled generalist outperforms separate bio and CS experts
“And maybe I would just add, you know, what happens if you don't have this, and you try to substitute this with an A-plus computer scientist joined with another person who's an A-plus biologist. The problem there is they just do not know what the other one does…”
Vijay Pande Jan 2, 2019 ▶ 38:47 a16z Podcast | Breaking Into Bio
Prediction Not checkable as stated
Pandey: Pharma companies will reframe themselves as data science companies
“Pharma companies will start to view themselves more as data generating companies and data science companies.”
Vijay Pande Jan 2, 2019 ▶ 9:06 a16z Podcast | When (and How) Biology Becomes Engineering
Prediction Not checkable as stated
Pandey: The future physical world will be engineered biology, not steel
“The future will not be steel and metal. It will be this sort of engineered biological thing that just grows, that has this function.”
Vijay Pande Jan 2, 2019 ▶ 11:58 a16z Podcast | When (and How) Biology Becomes Engineering
Prediction Not checkable as stated
Pande: AI early detection could be the missing link to curing cancer
“This is where AI could really be a part of the key missing link towards the cure to cancer.”
Vijay Pande Jan 2, 2019 ▶ 1:48 a16z Podcast | Taking the Pulse on Bio
Insight
Pande: Genomic diagnostics scale across cancer types via repeatable engineering
“Science is something that you can't schedule creativity or the ability to come through a breakthrough. So if you have understood the science of colorectal cancer, what you've learned about a stool test probably is not going to be very useful for a breast cance…”
Vijay Pande Jan 2, 2019 ▶ 7:12 a16z Podcast | Taking the Pulse on Bio
Insight
Pande: Data network effects never go off patent like biotech drugs
“Data network effects never go off patent. They just get stronger and stronger and help companies grow even after, even decades after.”
Vijay Pande Jan 2, 2019 ▶ 14:32 a16z Podcast | Taking the Pulse on Bio
Insight
Pande: Biological engineering requires predictive accuracy, not 100,000 empirical guesses
“It's all about, can you make predictions? So if you think you can engineer something, you should be able to make 10 predictions and have three work, not making a 100,000 guesses and seeing what pans out.”
Vijay Pande Jan 2, 2019 ▶ 14:35 a16z Podcast | Mindsets for Engineering Biology
Prediction Not checkable as stated
Pandey: Quantum computers will suddenly surpass classical computing at a specific threshold
“What will happen is a quantum computer at first will seem like it won't be all that useful. It will be below the number of qubits that you need. Maybe you need a hundred qubits to solve the problem and the existing machine only has 64. And so a classical compu…”
Vijay Pande Jan 2, 2019 ▶ 8:51 a16z Podcast | The Cloud Atlas to Real Quantum Computing
Prediction Not checkable as stated
Pandey: Quantum computers do not need 100,000 qubits to deliver useful chemistry simulations
“Or enzymes. It's all the chemistry, you know, so, so this is something where a quantum computer could be able to do calculations that are either much bigger at much higher accuracy where actually would be essentially much bigger at higher, much much higher acc…”
Vijay Pande Jan 2, 2019 ▶ 23:34 a16z Podcast | The Cloud Atlas to Real Quantum Computing
Prediction Not checkable as stated
Pande: Software will prove far more effective than small molecules for behavior
“I can imagine 10 years from now people would be like, well, what'd you expect? I mean, you wouldn't expect this small molecule that we didn't have like this Sense for how all of the human brain works and understanding behavior from a fomental molecular biologi…”
Vijay Pande Jan 2, 2019 ▶ 5:48 a16z Podcast | The Rise of the Digital 'Pill'
Opinion
Pande: Digital therapeutics data moats outperform traditional pharmaceutical patents
“And you have an interesting barrier to entry that is far superior than something like patents.”
Vijay Pande Jan 2, 2019 ▶ 8:29 a16z Podcast | The Rise of the Digital 'Pill'
Prediction Not checkable as stated
Pande: AI will accelerate doctors long before replacing them
“And I think before we talk about replacing doctors at all, that doesn't make any sense when we could be accelerating them. Exactly. And having them do so much more. And I, I'm pretty sure we'll see that first. Just like you don't think a word processor with a …”
Vijay Pande Jan 2, 2019 ▶ 16:59 a16z Podcast | The Rise of the Digital 'Pill'

Show 24statements(173 left)

The other half of the tape: Vijay Pande's own voice is left out of every number here. Other people bring the name up 5 times in 5 episodes on the a16z Podcast. 1 statement on the record names them. every mention, with the transcript →

Who brings them up most Steph Smith 2Sonal Chokshi 1Marc Andreessen 1Ben Horowitz 1

Statements about Vijay Pande, by other people (1)

Assertion Supported
Horowitz: QBio built an MRI scanner that completes scans in 10 minutes
“We have a company in in Vijay's portfolio called QBio, which has built an MRI scanner that can kind of basically scan you in 10 minutes instead of an hour, and it's much cheaper and so forth.”
Ben Horowitz Dec 20, 2023 ▶ 1:05:15 Tony Robbins on the Future of Health & Longevity

Every mention by year

tap a year for its mentions
0011222019202020212022202320242025episodesmentions
0122019202020212022202320242025episodes it came up in
000.51122019202020212022202320242025episodesmentions per episode
2025 1 mention in 1 episode
2024 1 mention in 1 episode
2023 2 mentions in 2 episodes 1 per episode
2019 1 mention in 1 episode

Appearances (38)

EpisodeDateSpeaking time
Hey Tech, Come to Healthcare May 30, 2025 13m
7 More Healthy Years: What We Can Learn from Super Agers May 27, 2025 3m
AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu Oct 3, 2024 6m
Implementation, Data, Impact of Healthcare AI with Julie and Vijay Sep 5, 2024 13m
AI in Pharmaceutical R&D with Kim Branson Aug 1, 2024 2m
Grand Challenges in Healthcare AI with Vijay Pande and Julie Yoo Jun 28, 2024 13m
Fireside Chat with Sean Duffy Jan 4, 2024 6m
Tony Robbins on the Future of Health & Longevity Dec 20, 2023 8m
Digital Biology with insitro's Daphne Koller Sep 25, 2023 3m
2023 Big Ideas in Technology (Part 2) Jan 27, 2023 4m
Expert AI as a Healthcare Superpower Jan 9, 2023 15m
Food, Drugs, and Tech: 100 years of Public Health Jan 6, 2020 9m
a16z Podcast | Incenting Innovation Inside, Loonshots to Moonshots Apr 1, 2019 8m
a16z Podcast | All About Synthetic Biology Jan 17, 2019 3m
a16z Podcast | Dark Data in Healthcare Jan 17, 2019 6m
a16z Podcast | The Science and Business of Innovative Medicines Jan 17, 2019 4m
a16z Podcast | Breaking Into Bio Jan 2, 2019 4m
a16z Podcast | When (and How) Biology Becomes Engineering Jan 2, 2019 11m
a16z Podcast | Taking the Pulse on Bio Jan 2, 2019 6m
a16z Podcast | Putting AI in Medicine, in Practice Jan 2, 2019 2m
a16z Podcast | Mindsets for Engineering Biology Jan 2, 2019 8m
a16z Podcast | The Taxonomy of Collective Knowledge Jan 2, 2019 1m
a16z Podcast | The Cloud Atlas to Real Quantum Computing Jan 2, 2019 6m
a16z Podcast | What Technology Wants, Needs, Does Jan 2, 2019 4m
a16z Podcast | The Rise of the Digital 'Pill' Jan 2, 2019 7m
a16z Podcast | The Science Of Extending Life Jan 2, 2019 4m
a16z Podcast | The Business of Healthcare Jan 2, 2019 3m
a16z Podcast | Health Data -- A Feedback Loop for Humanity Jan 2, 2019 4m
a16z Podcast | On the Genomics of Disease, From Science to Business Jan 2, 2019 6m
a16z Podcast | Move Fast But Don't Break Things (When It Comes to Computational Biology) Jan 2, 2019 6m
a16z Podcast | Data Network Effects Jan 2, 2019 5m
a16z Podcast | When Bio Meets Computer Science Jan 2, 2019 25m
a16z Podcast | The Cool Stuff Only Happens at Scale Jan 2, 2019 6m
a16z Podcast | Startups as Science Experiments -- Can VC Disrupt Academia? Jan 2, 2019 5m
Shifting Risk Mindsets, from Tech to Bio Apr 30, 2018 6m
Pande & Conde: When (and How) Biology Becomes Engineering Mar 23, 2018 11m
When Biology Moves to Engineering Jan 11, 2018 20m
On Machine Learning in Medicine and More Jul 15, 2017 9m

Played on the show (2)

Episodes where a recording of Vijay Pande was played rather than Vijay taking part, or where the tape carries an address with nobody putting questions to them. Listed because the words are on the record, kept out of every score on this page because they were not said on this show. We read this off the tape: who was spoken to, who was asked something, who answered whom.

EpisodeDateOn tapeWhat it is
AI is Industrializing Discovery Nov 21, 2019 18m aired address
a16z Podcast | The Genetics Of Drug Delivery Jan 2, 2019 53s clip played
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.